UCP2 and breast carcinoma: Interestingly, decreased cell proliferation rate was observed in MCF-7/Dox transduced with UCP-2 shRNA compared to shScramble, which indicated that UCP-2 might mediate the Doxorubicin resistance in breast cancer cells.